Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

Multiple treatments work best for hair loss.

DHT, a testosterone byproduct, causes male pattern baldness.

Spironolactone helps regrow hair in women with hair loss.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Women's hair generally gets thinner and less dense starting in their mid-thirties, with hair loss becoming more common as they age due to both genetics and environment.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.